Assyro AI

FDA Orange Book · active-ingredient family

Olive oil; soybean oil

Olive oil; soybean oil is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:CLINOLIPID 20% · NDA 204508

1

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

1

Exclusivity periods

Brand (NDA) products · emulsion

ProductApplicantApplicationTEApproved
CLINOLIPID 20%RLDBAXTER HLTHCARE CORPNDA 204508Oct 03, 2013

Marketing exclusivity (1)

  • NPPNew patient population exclusivity (3 years)

    Apr 24, 2027

    in 10 mo

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Olive oil; soybean oil — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.